About - Sobi About us Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases We are dedicated to capturing the scientific opportunities of our time With our early roots in Sweden, we started as pioneers in Haemophilia Today we are an innovative leader within rare diseases with a global reach We are bringing
Careers - Sobi At Sobi everything starts with people Understanding unmet medical needs is at our core Combining this understanding with the capabilities in clinical development is our key to success We have accumulated a strong expertise in rapidly and efficiently reaching people living with rare diseases with breakthrough therapies Sobi’s operational network and strong professional relationships with
Medicines | Sobi Discover Sobi’s key medicines and partner products for rare diseases, including haemophilia, rare kidney conditions, and immunological disorders
Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the . . . Sobi® Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia In 2024, revenue amounted to SEK 26 billion
At a glance - Sobi At a glance Bringing brilliant ideas to life Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases Sobi in short: Global footprint with own presence in around 30 countries, delivering medicines to patients in many more Approximately 1,900 employees across Europe, North America, the Middle East
トップページ | Sobi Japan 希少疾患の患者さんのために Sobiは、希少疾患の患者さんの生活を改善するために、革新的な治療法を開発し提供しています。
Pipeline - Sobi Pipeline We see innovation as essential to our vision of being a global leader in rare diseases We need to reinvest in research and development to continue providing innovative treatments, creating new evidence, and expanding the use of our medicines Major ongoing clinical studies and medicines in registration in a major region or country Updated: 19 March 2026
Sobi | Sobi France Sobi est une société biopharmaceutique internationale qui révèle le potentiel des thérapies innovantes et transforme le quotidien des personnes vivant avec une maladie rare